Bristol-Myer Squibb Company (NYSE:BMY) Q3 2023 Earnings Conference Call October 26, 2023 8:00 AM ET

Company Participants

Giovanni Caforio - Chairman, Chief Executive Officer

Chris Boerner - Chief Operating Officer

David Elkins - Executive Vice President, Chief Financial Officer

Adam Lenkowsky - Chief Commercialization Officer

Sarnit Hirawat - Chief Medical Officer

Tim Power - Vice President, Investor Relations

Conference Call Participants

Chris Schott - JP Morgan

Geoff Meacham - Bank of America

Luisa Hector - Berenberg

Seamus Fernandez - Guggenheim

Chris Shibutani - Goldman Sachs

Steven Scala - TD Cowen

Terence Flynn - Morgan Stanley

Evan Siegerman - BMO Capital Markets

Carter Gould - Barclays

Andrew Baum - Citi

Tim Anderson - Wolfe Research

David Risinger - Leerink Partners

Robyn Karnauskas - Truist

Mohit Bansal - Wells Fargo

Olivia Brayer - Cantor Fitzgerald

Sean - Raymond James

Operator

Hello and welcome to the Bristol-Myers Squibb third quarter 2023 earnings conference call.

All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today’s presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded.

I would now like to turn the conference over to Tim Power, Vice President of Investor Relations. Please go ahead.

Tim Power

Thank you and good morning everyone. Thank you for joining us this morning for our third quarter 2023 earnings call.

Joining me this morning with prepared remarks are Giovanni Caforio, our Board Chair and Chief Executive Officer; Chris Boerner, our Chief Operating Officer and CEO designate; and David Elkins, our Chief Financial Officer. Also participating in today’s call are Adam Lenkowsky, our Chief Commercialization Officer, and Sarnit Hirawat, our Chief Medical Officer and Head of Global Drug Development. As you’ll note, we’ve posted slides to bms.com that you can use to follow along with Giovanni, Chris and David’s remarks.

Before we get started, I’ll read our forward-looking statement.

During this call, we make statements about the company’s future plans and prospects that constitute forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the company’s SEC filings. These forward-looking statements represent our estimates as of today and should not be relied upon as representing our estimates as of any future date. We specifically disclaim any obligation to update forward-looking statements, even if our estimates change.